P

PharmaCyte Biotech
D

PMCB

1.78000
USD
-0.04
(-2.20%)
مغلق
حجم التداول
206
الربح لكل سهم
0
العائد الربحي
0
P/E
3
حجم السوق
13,668,700
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ALT
    -0.27000
    (-4.24%)
    6.10000 USD
    D
    DVAX
    -0.280
    (-2.50%)
    10.910 USD
    I
    IBIO
    -0.01000
    (-0.48%)
    2.06000 USD
    I
    INO
    -0.670
    (-6.28%)
    10.000 USD
    N
    NNVC
    -0.05000
    (-2.33%)
    2.10000 USD
    N
    NVAX
    -0.250
    (-1.95%)
    12.560 USD
    V
    VXRT
    -0.01170
    (-1.74%)
    0.65890 USD
    المزيد
الأخبار
المقالات

العنوان: PharmaCyte Biotech

القطاع: Healthcare
الصناعة: Biotechnology
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulationtechnology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.